{"id":6184,"date":"2023-09-04T13:00:04","date_gmt":"2023-09-04T13:00:04","guid":{"rendered":"https:\/\/www.nfp-drugs.bg\/en\/?p=6184"},"modified":"2023-12-28T11:33:16","modified_gmt":"2023-12-28T11:33:16","slug":"issue-11-of-news-bulletin-for-the-new-psychoactive-substances","status":"publish","type":"post","link":"https:\/\/www.nfp-drugs.bg\/en\/issue-11-of-news-bulletin-for-the-new-psychoactive-substances\/","title":{"rendered":"Issue 11 of NEWS bulletin for the new psychoactive substances"},"content":{"rendered":"\n<p>In issue 11 of the edition of the National Focal Point on Drugs and Drug Addictions NEWS \u2013 Bulletin for the new psychoactive substances you will find the following topics:<\/p>\n\n\n\n<ul>\n<li>New psychoactive substances identified in Bulgaria in the first half of 2023.<\/li>\n\n\n\n<li>New psychoactive substances identified in Europe in the first half of 2023.<\/li>\n\n\n\n<li>Normative change in determination of drug prices for the needs of court proceedings.<\/li>\n\n\n\n<li>Focus on: CH-FUBIACA, MDMB-7BR-INACA, MDMB-INACA, HHC-O, HHC-P, dipentylone, 2C-B-FLY, alpha-methylfentanyl.<\/li>\n\n\n\n<li>European Drug Report 2023. &nbsp;Overview of new psychoactive substances on the European level.<\/li>\n\n\n\n<li>World Drug Report 2023. Global overview of new psychoactive substances.\u00a0<\/li>\n<\/ul>\n\n\n\n<p><strong><a href=\"https:\/\/www.nfp-drugs.bg\/en\/wp-content\/uploads\/2023\/09\/NEWS_11.pdf\">Issue 11 of NEWS (in Bulgarian)<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>In issue 11 of the edition of the National Focal Point on Drugs and Drug Addictions NEWS \u2013 Bulletin for the new psychoactive substances you will find the following topics: Issue 11 of NEWS (in Bulgarian)<\/p>\n","protected":false},"author":1,"featured_media":6182,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[],"_links":{"self":[{"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/posts\/6184"}],"collection":[{"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/comments?post=6184"}],"version-history":[{"count":5,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/posts\/6184\/revisions"}],"predecessor-version":[{"id":6220,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/posts\/6184\/revisions\/6220"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/media\/6182"}],"wp:attachment":[{"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/media?parent=6184"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/categories?post=6184"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/tags?post=6184"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}